MAPS submitted the MDMA/PTSD protocol for review to the Independent Review Consulting Institutional Review Board (IRC-IRB), with the protocol to be discussed by the review board on January 2, 2003. Officials at the IRC-IRB have read the entire correspondence between MAPS and the Western IRB and have indicated that they will carefully review the protocol on its merits without bias due to the controversial nature of MDMA-assisted psychotherapy research. This IRB has a reputation for being rigorous but fair, a set of characteristics that inspires confidence.
